Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Full activity resumption becomes possible for many
Heres the realistic timeline: Phase 3 trials (AMAZE program): - AMAZE 1 (obesity) started February 2026, enrolling ~1,150 participants - Primary completion estimated: June 2029 - Phase 3 in T2D also being planned following the ADA 2026 data US FDA approval (projected): Q4 2030 at the earliest (GlobalData estimate) EU EMA approval (projected): Q1 2031 at the earliest Bulgaria and Eastern Europe: Typically 612 months after EMA approval for market access, depending on national reimbursement negotiations
B12 injections are most appropriate for people with confirmed or suspected B12 deficiency
These sessions adjust your treatment plan based on how your body responds to the injections
US$ 28.31
US$ 24.28
US$ 23.02
US$ 29.68
US$ 27.17
US$ 25.59
US$ 27.50
